RS10426201 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (7)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| 5alpha-androstan-3alpha,17beta-diol monosulfate (2) levels | A | OR: 0.45 | 7E-78 | PubMed |
| Cholelithiasis (UKB data field 20002_1162) | — | OR: 0.85 | 2E-28 | PubMed |
| Vitamin D insufficiency | G | OR: 0.11 | 8E-20 | PubMed |
| Metabolite levels (21-hydroxypregnenolone disulfate) | A | OR: 0.2 | 9E-18 | PubMed |
| 5alpha-androstan-3beta,17alpha-diol disulfate levels | A | OR: 0.18 | 3E-16 | PubMed |
| 3b-hydroxy-5-cholenoic acid levels | A | OR: 0.16 | 9E-13 | PubMed |
| Androstenediol (3alpha, 17alpha) monosulfate (2) levels in elite athletes | — | OR: 0.52 | 2E-10 | PubMed |